Cortistatin reduces atherosclerosis in hyperlipidemic ApoE-deficient mice and the formation of foam cells

DSpace/Manakin Repository

Cortistatin reduces atherosclerosis in hyperlipidemic ApoE-deficient mice and the formation of foam cells

Citable link to this page

 

 
Title: Cortistatin reduces atherosclerosis in hyperlipidemic ApoE-deficient mice and the formation of foam cells
Author: Delgado-Maroto, Virginia; Benitez, Raquel; Forte-Lago, Irene; Morell, Maria; Maganto-Garcia, Elena; Souza-Moreira, Luciana; O’Valle, Francisco; Duran-Prado, Mario; Lichtman, Andrew H.; Gonzalez-Rey, Elena; Delgado, Mario

Note: Order does not necessarily reflect citation order of authors.

Citation: Delgado-Maroto, V., R. Benitez, I. Forte-Lago, M. Morell, E. Maganto-Garcia, L. Souza-Moreira, F. O’Valle, et al. 2017. “Cortistatin reduces atherosclerosis in hyperlipidemic ApoE-deficient mice and the formation of foam cells.” Scientific Reports 7 (1): 46444. doi:10.1038/srep46444. http://dx.doi.org/10.1038/srep46444.
Full Text & Related Files:
Abstract: Atherosclerosis is a chronic inflammatory cardiovascular disease that is responsible of high mortality worldwide. Evidence indicates that maladaptive autoimmune responses in the arterial wall play critical roles in the process of atherosclerosis. Cortistatin is a neuropeptide expressed in the vascular system and atherosclerotic plaques that regulates vascular calcification and neointimal formation, and inhibits inflammation in different experimental models of autoimmune diseases. Its role in inflammatory cardiovascular disorders is largely unexplored. The aim of this study is to investigate the potential therapeutic effects of cortistatin in two well-established preclinical models of atherosclerosis, and the molecular and cellular mechanisms involved. Systemic treatment with cortistatin reduced the number and size of atherosclerotic plaques in carotid artery, heart, aortic arch and aorta in acute and chronic atherosclerosis induced in apolipoprotein E-deficient mice fed a high-lipid diet. This effect was exerted at multiple levels. Cortistatin reduced Th1/Th17-driven inflammatory responses and increased regulatory T cells in atherosclerotic arteries and lymphoid organs. Moreover, cortistatin reduced the capacity of endothelial cells to bind and recruit immune cells to the plaque and impaired the formation of foam cells by enhancing cholesterol efflux from macrophages. Cortistatin emerges as a new candidate for the treatment of the clinical manifestations of atherosclerosis.
Published Version: doi:10.1038/srep46444
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5390288/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:32630618
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters